X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (231) 231
Publication (9) 9
Book / eBook (2) 2
Book Review (2) 2
Book Chapter (1) 1
Conference Proceeding (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (92) 92
humans (91) 91
male (70) 70
female (64) 64
middle aged (48) 48
adult (45) 45
aged (39) 39
oncology (33) 33
cancer (30) 30
gastroenterology & hepatology (23) 23
neurosciences (18) 18
analysis (17) 17
care and treatment (17) 17
prognosis (17) 17
tumors (17) 17
aged, 80 and over (16) 16
hepatocellular carcinoma (16) 16
patients (16) 16
sorafenib (16) 16
chemotherapy (15) 15
treatment outcome (15) 15
colorectal cancer (14) 14
retrospective studies (14) 14
neoplasm staging (13) 13
pain (13) 13
surgery (13) 13
time factors (13) 13
young adult (13) 13
carcinoma, hepatocellular - pathology (12) 12
liver neoplasms - pathology (12) 12
research (12) 12
survival (12) 12
metastasis (11) 11
psychology (11) 11
touch (11) 11
carcinoma (10) 10
carcinoma, hepatocellular - drug therapy (10) 10
gastroenterology and hepatology (10) 10
liver cancer (10) 10
liver neoplasms - drug therapy (10) 10
medicine & public health (10) 10
survival rate (10) 10
cancer therapies (9) 9
hand - physiology (9) 9
hepatoma (9) 9
liver neoplasms - mortality (9) 9
medical prognosis (9) 9
mortality (9) 9
research article (9) 9
therapy (9) 9
antineoplastic combined chemotherapy protocols - therapeutic use (8) 8
article (8) 8
follow-up studies (8) 8
health aspects (8) 8
immunotherapy (8) 8
liver (8) 8
multidisciplinary sciences (8) 8
mutations (8) 8
mutl protein homolog 1 (8) 8
perception (8) 8
proportional hazards models (8) 8
urinary bladder neoplasms - pathology (8) 8
urinary bladder neoplasms - surgery (8) 8
urology (8) 8
urology & nephrology (8) 8
bevacizumab (7) 7
diagnosis (7) 7
digestive system diseases (7) 7
disease-free survival (7) 7
expression (7) 7
germany (7) 7
illusions - physiology (7) 7
liver diseases (7) 7
medicine (7) 7
psychology, experimental (7) 7
psychophysics (7) 7
regression analysis (7) 7
risk factors (7) 7
science (7) 7
skin (7) 7
studies (7) 7
abridged index medicus (6) 6
biomarkers (6) 6
biomedicine (6) 6
carcinoma, hepatocellular - mortality (6) 6
cirrhosis (6) 6
colorectal neoplasms, hereditary nonpolyposis - genetics (6) 6
cortex (6) 6
development and progression (6) 6
dna (6) 6
efficacy (6) 6
endoscopy (6) 6
further section · weitere sektion (6) 6
hematology, oncology and palliative medicine (6) 6
liver cirrhosis (6) 6
localization (6) 6
met (6) 6
multivariate analysis (6) 6
patient outcomes (6) 6
pharmacology & pharmacy (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet, ISSN 0140-6736, 05/2019, Volume 393, Issue 10184, pp. 1948 - 1957
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10088, pp. 2492 - 2502
Summary Background For patients with advanced hepatocellular carcinoma, sorafenib is the only approved drug worldwide, and outcomes remain poor. We aimed to... 
Internal Medicine | CELL LUNG-CANCER | MEDICINE, GENERAL & INTERNAL | EFFICACY | SAFETY | IMMUNOTHERAPY | SORAFENIB | BLOCKADE | DOCETAXEL | PD-1 | Drug Administration Schedule | Humans | Antibodies, Monoclonal - adverse effects | Liver Neoplasms - drug therapy | Male | Response Evaluation Criteria in Solid Tumors | Treatment Outcome | Antineoplastic Agents - administration & dosage | Tumor Burden | Dose-Response Relationship, Drug | B7-H1 Antigen - metabolism | Carcinoma, Hepatocellular - drug therapy | Time Factors | Antibodies, Monoclonal - administration & dosage | Antineoplastic Agents - adverse effects | Nivolumab | Carcinoma, Hepatocellular - pathology | Biomarkers, Tumor - metabolism | Female | Liver Neoplasms - pathology | Aged | Virus diseases | Medical colleges | Care and treatment | Cell death | College teachers | Hepatoma | Comparative analysis | Drug approval | Slopes | Therapy | Pemphigoid | Intravenous administration | Inhibitor drugs | PD-1 protein | Funding | Liver | Medical services | Clinical trials | Hepatocellular carcinoma | Lymphocytes T | Infections | Metastasis | Dosage | Cancer therapies | B7 antigen | Acceptability | Incidence | Hepatitis | Liver cancer | Pathways | Quality | Immunotherapy | Safety engineering | Safety management | Safety | Expansion | Drug dosages | Liver diseases | Effectiveness | Mortality | Group dynamics | Patients | Hospitals | Inhibitors | Immune checkpoint | Adults | Solid tumors | Hepatitis C virus | Hepatitis C | Tumors | Apoptosis
Journal Article
Der Onkologe, ISSN 0947-8965, 9/2018, Volume 24, Issue 9, pp. 720 - 724
Die Therapieoptionen bei Patienten mit hepatozellulärem Karzinom (HCC) nach Versagen einer Therapie mit Sorafenib sind derzeit weiterhin eingeschränkt.... 
Gastrointestinale Tumoren | Liver failure | Leberversagen | Liver diseases | Medicine & Public Health | Lebererkrankungen | Leberzirrhose | Oncology | Gastrointestinal neoplasms | Liver cirrhosis | Liver neoplasms | Leberneoplasien
Journal Article
Onkologe, ISSN 0947-8965, 09/2018, Volume 24, Issue 9, pp. 720 - 724
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2011, Volume 6, Issue 10, p. e26971
Background: MicroRNA-21 (miR-21) is up-regulated in tumor tissue of patients with malignant diseases, including hepatocellular carcinoma (HCC). Elevated... 
CIRCULATING MICRORNAS | MIR-122 | ACTIVATION | SUPPRESSOR GENE | BIOMARKER | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | MIR-21 | INFECTION | EXPRESSION | TUMORS | Multivariate Analysis | Hepatitis C, Chronic - pathology | gamma-Glutamyltransferase - blood | Humans | Middle Aged | Liver Neoplasms - complications | Male | Alanine Transaminase - blood | Hepatitis C, Chronic - complications | Inflammation - blood | Necrosis | Liver Neoplasms - blood | Inflammation - complications | Carcinoma, Hepatocellular - complications | Hepatitis C, Chronic - enzymology | Female | Liver Neoplasms - pathology | Carcinoma, Hepatocellular - blood | Reproducibility of Results | Biomarkers - blood | Hepatitis C, Chronic - blood | Bilirubin - blood | Aspartate Aminotransferases - blood | Carcinoma, Hepatocellular - pathology | MicroRNAs - blood | Cohort Studies | Serum Albumin - metabolism | Infection | MicroRNA | Liver | Aspartate | Development and progression | Hepatoma | Bilirubin | Hepatitis C virus | Health aspects | Correlation | Colorectal cancer | Chronic infection | Viruses | Hepatocellular carcinoma | Alcohol | Infections | Multivariate analysis | Hepatitis | Liver cancer | Alanine | Liver diseases | MiRNA | Patients | Medicine | Serum levels | Ribonucleic acids | Biopsy | MicroRNAs | Medical prognosis | Alanine transaminase | Biomarkers | Aspartate aminotransferase | Interferon | Hepatitis C | Prostate | Tumors
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 1, pp. 55 - 63
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 12, pp. 1697 - 1708
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 12417 - 9
In the rubber hand illusion (RHI), synchronous touch of a real hand and an artificial hand leads to the feeling of the artificial hand belonging to one's own... 
BODILY SELF-CONSCIOUSNESS | BODY OWNERSHIP | PERCEPTION | PAIN | CORTEX | INTEROCEPTION | FEEL | MULTIDISCIPLINARY SCIENCES | TOUCH | PHYSIOLOGICAL CONDITION | ILLUSORY OWNERSHIP | Temperature effects | Sensory integration | Visual stimuli | Tactile stimuli | Rubber | Thermal stimuli | Visual perception
Journal Article